Alair bronchial thermoplasty system for adults with severe difficult to control asthma

References

Bicknell S, Chaudhuri R, Lee N, et al. (2015) Effectiveness of bronchial thermoplasty in severe asthma in 'real life' patients compared with those recruited to clinical trials in the same centre. Therapeutic Advances in Respiratory Disease 9(6) 267–71

British Thoracic Society, Scottish Intercollegiate Guidelines Network (2014) British guideline on the management of asthma: A national clinical guideline. SIGN 141. [online; accessed 15 February 2016]

Burn J, Sims AJ, Keltie K, et al. (2015) on behalf of the British Thoracic Society (BTS) UK Difficult Asthma Registry participants. Audit of the safety of Bronchial Thermoplasty using a national register and Hospital Episode Statistics. Thorax 70: Supplement

Castro M, Rubin AS, Laviolette M, et al. (2010) Effectiveness and safety of BT in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. American Journal of Respiratory Critical Care Medicine 181(2):116–24

Castro M, Rubin A, Laviolette M, et al. (2011), for the AIR2 Trial Study Group. Persistence of effectiveness of BT in patients with severe asthma. Annals of Allergy, Asthma and Immunology 107:65–70

Chung KF, Wenzel SE, Brozek JL, et al. (2014) International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. European Respiratory Journal 43:343–73

Cox G, Thomson NC, Rubin AS, et al. (2007) Asthma control during the year after bronchial thermoplasty. New England Journal of Medicine 356:1327–37

Department of Health (2015) National Schedule of NHS Reference Costs 2014/15. [online; accessed 7 January 2016]

Facciolongo N, Di Stefano A, Pietrini V, et al. (2015) The effect of bronchial thermoplasty on nerve C-fibers and inflammatory cells in patients with severe asthma. European Respiratory Journal 46: Supplement 59

Health and Social Care Information Centre (2015) Quality and Outcomes Framework – Prevalence, Achievements and Exceptions Report: England, 2014–15. [online; accessed 16 February 2016]

Health and Social Care Information Centre (2015) Hospital Episode Statistics: admitted patient care England 2014–15: Diagnosis. [online; accessed 12 January 2016]

National Institute for Health Research Horizon Scanning Centre (2011) Alair BT System for Severe Asthma. [online; accessed 16 February 2016]

National Institute for Health Research Horizon Scanning Centre (2012) Updated: Alair BT system for severe asthma. [online; accessed 26 December 2015]

NHS England (2013) 2013/14 NHS standard contract for respiratory: severe asthma (adult) particulars, schedule 2- The services, A- service specifications. [online; accessed 23 December 2015]

National Institute for Health and Care Excellence (2012) Interventional procedure guidance [IPG419]. Bronchial thermoplasty for severe asthma. [online; accessed 16 December 2015]

National Institute for Health and Care Excellence (2013) Technology appraisal guidance [TA278]: Omalizumab for treating severe persistent allergic asthma. [online; accessed 16 December 2015]

National Institute for Health and Care Excellence (2015) Asthma: the management of asthma. Guideline scope. [online; accessed 23 December 2015]

National Institute for Health and Care Excellence (2016) Asthma pathway. [online; accessed 10 January 2016]

Pavord ID, Cox G, Thomson NC, et al. (2007) Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma. American Journal of Respiratory Critical Care Medicine 176(12):1185–91

Pavord ID, Thomson NC, Niven RM, et al. (2013), for the RISA Trial Study Group. Safety of BT in patients with severe refractory asthma. Annals of Allergy, Asthma & Immunology 111(5):402–7

Pretolani M, Dombret,MC Thabut G, et al. (2014) Reduction of airway smooth muscle mass by bronchial thermoplasty in patients with severe asthma. American Journal of Respiratory and Critical Care Medicine 190(12):1452–4

Simpson CR, Sheikh A (2010) Trends in the epidemiology of asthma in England: a national study of 333,294 patients. Journal of the Royal Society of Medicine 103:98–106. [online; accessed 23 December 2015]

Thomson NC, Rubin AS, Niven RM, et al. (2011) Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial. BMC Pulmonary Medicine 11:8

Torrego A, Solà I, Munoz AM, et al. (2014) Bronchial thermoplasty for moderate or severe persistent asthma in adults. Cochrane Database of Systematic Reviews 3:CD009910.

Wechsler ME, Laviolette M, Rubin AS, et al. (2013) Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma. Journal of Allergy and Clinical Immunology 132(6):1295–302

Wu Q, Xing Y, Zhou X, et al. (2011) Meta-analysis of the efficacy and safety of BT in patients with moderate-to-severe persistent asthma. Journal of International Medical Research 39(1):10–22

Zafari Z, Sadatsafavi M, Marra CA, Chen W, FitzGerald JM (2016) Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma. PLoS ONE 11(1): e0146003.

Zein JG, Menegay MC, Singer ME, et al. (2015) Cost effectiveness of bronchial thermoplasty in patients with severe uncontrolled asthma. Journal of Asthma 1–7

Zhou JP, Feng Y, Wang Q, et al. (2015) Long-term efficacy and safety of BT in patients with moderate-to-severe persistent asthma: a systemic review and meta-analysis. Journal of Asthma: 1–7